IP Library Patent Application 17257387
Patent Application
App. No. 17/257,387

REAGENT AND PROCESS FOR THE SITE-SPECIFIC DEOXYFLUORINATION OF PEPTIDES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/257,387
Abstract

The present invention refers to reagents and methods for preparing a peptide sequence having a [ 18 F]fluoro-aromatic amino acid side which may be further substituted, in particular a 4-[ 18 F]fluoro-phenylalanine side chain in peptide sequences, by chemoselective radio-deoxyfluorination of an aromatic amino acid residue, in particular a tyrosine residue using a traceless-activating group and the reagents used in said process.

Claims (18)

1 . A [P-AR 1 (RuCp)-OH] complex having the general formula (I):

wherein AR 1 is an aromatic or heteroaromatic hydrocarbon having 5 to 14 carbon atoms, which may be further substituted by at least one C 1 to C 6 alkyl group and/or by at least one heteroatom,

wherein Y is an anion; n is 0 or 1; and P is a protective group.

2 . A [P-AR 1 (RuCp)-OH] complex having the general formula (I) as defined in claim 1 , wherein AR 1 is phenyl, 4-hydroxy-phenyl- or 1H-indol-3-yl, and Y, n and P have the meaning as defined in claim 1 .

3 . A [AR 1 (RuCp)-OH] complex having the general formula (IV):

wherein AR 1 is an aromatic or heteroaromatic hydrocarbon having 5 to 14 carbon atoms, which may be further substituted by at least one C 1 to C 6 alkyl group and/or at least one heteroatom; Y is an anion; and n is 0 or 1.

4 . A [AR 1 (RuCp)-OH] complex having the general formula (IV) as defined in claim 3 , wherein AR 1 is phenyl, 4-hydroxy-phenyl- or 1H-indol-3-yl; Y is an anion; and n is 0 or 1.

5 . Method of using the [P-AR 1− (RuCp)-OH] − complex (I) as defined in claim 1 in a solid phase peptide synthesis.

6 . An oligo- or polypeptide having at least one amino acid residue of the formula (V)

incorporated into an amino acid backbone of the oligo- or polypeptide, wherein AR 1 is an aromatic or heteroaromatic hydrocarbon having 5 to 14 carbon atoms, which may be further substituted by at least one C 1 to C 6 alkyl group and/or by at least one heteroatom.

7 . An oligo- or polypeptide having at least one amino acid residue of the formula (V) in the amino acid backbone according to claim 6 , wherein AR 1 is phenyl; 4-hydroxy-phenyl- or 1H-indol-3-yl:

8 . Method of using an oligo- or polypeptide as defined in claim 6 for preparing a diagnostic composition for positron emission tomography (PET).

9 . Method of using a Ruthenium complex for preparing a Ruthenium-peptide complex for radiolabeling, wherein the Ruthenium complex has the general formula (VI):

wherein L represents a soft ligand; X − represents a weak coordinating anion; and the peptide is an oligopeptide or a polypeptide, wherein at least one of the amino acids of the peptide comprises a hydroxy-indole residue or a hydroxy-phenyl residue.

10 . Process for preparing an oligo- or polypeptide of claim 7 having at least one amino acid residue of the formula (V) in the amino acid backbone, wherein AR 1 is phenyl; 4-hydroxy-phenyl- or 1H-indol-3-yl,

said process comprising reacting an oligo- or polypeptide having at least one amino acid complex of the formula (IV) incorporated into an amino acid backbone of said oligo- or polypeptide:

wherein AR 1 is an aromatic or heteroaromatic hydrocarbon having 5 to 14 carbon atoms, which may be further substituted by at least one C 1 to C 6 alkyl group and/or at least one heteroatom; Y is an anion; and n is 0 or 1;

with a fluorine source in the presence of an imidazolium chloride and optionally in the presence of an oxalate compound, selected from bis(trimethylneopentylammonium) oxalate or Kryptand 2.2.2 and alkali oxalate, to fluorinate the AR 1 compound, thereby providing an oligo- or polypeptide having a fluorinated AR 1 compound as illustrated in the following scheme:

Assignments (2)
CHANGE OF NAME Recorded Feb 27, 2023
From: STUDIENGESELLSCHAFT KOHLE MBH
To: STUDIENGESELLSCHAFT KOHLE GGMBH
Reel/Frame 062876/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2020
From: RITTER, TOBIAS; RICKMEIER, HENRICK JENS
To: STUDIENGESELLSCHAFT KOHLE MBH
Reel/Frame 054784/0782 →